GenFleet Therapeutics (Shanghai) Inc. Stock
Stocks
2595
CNE1000074L2
Biotechnology & Medical Research
|
Delayed
Hong Kong S.E.
22:28:46 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 31.06 HKD | -1.15% |
|
+3.34% | +29.94% |
| 08-10 | GenFleet Therapeutics's Lung Cancer Drug Advances in Phase 3 Trial, First Patient Dosed | MT |
| 07-15 | GenFleet Therapeutics Seeks HK$467 Million via H-Share Placement; Shares Up 11% | MT |
| Market Cap | 10B 11.64B 1.48B 1.29B 1.21B 1.1B 2.07B 142B 2.1B 14.19B 5.54B 70.85B 5.57B 5.45B 236B | P/E 2026 * |
-25.6x | P/E 2027 * | -36.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.2B 10.7B 1.36B 1.18B 1.11B 1.01B 1.9B 130B 1.93B 13.04B 5.09B 65.13B 5.12B 5.01B 217B | EV / Sales 2026 * |
54.5x | EV / Sales 2027 * | 59.3x |
| Free-Float |
73.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.65% | ||
| 1 week | +3.34% | ||
| Current month | +11.39% | ||
| 1 month | -19.57% | ||
| 3 months | -14.45% | ||
| 6 months | +3.28% | ||
| Current year | +29.94% |
| 1 week | 29 |  | 32.58 |
| 1 month | 26.14 | | 44.26 |
| Current year | 19.6 | | 52.9 |
| 1 year | 19.6 | | 52.9 |
| 3 years | 19.6 | | 52.9 |
| 5 years | 19.6 | | 52.9 |
| 10 years | 19.6 | | 52.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jiong Lan
CEO | Chief Executive Officer | 53 | 2017-08-21 |
Yu Wang
CTO | Chief Tech/Sci/R&D Officer | - | 2020-10-31 |
Wei Zhang
SEC | Corporate Secretary | 47 | 2026-03-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Jiong Lan
BRD | Director/Board Member | 53 | 2017-08-21 |
Qiang Lü
CHM | Chairman | 41 | 2017-08-21 |
Wei Zhang
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.15% | +3.34% | - | - | 1.43B | |
| +2.07% | +13.76% | +65.44% | +106.53% | 70.1B | |
| -0.87% | +0.08% | +36.96% | +65.91% | 54.93B | |
| -4.50% | -4.69% | +2.82% | +463.22% | 28.89B | |
| -0.61% | -0.87% | +47.50% | +6.84% | 23.9B | |
| -0.67% | +1.02% | -18.32% | -13.84% | 23.3B | |
| -0.59% | +7.88% | +40.87% | -20.56% | 18.77B | |
| +0.35% | +12.02% | +257.19% | +466.50% | 18.41B | |
| -0.48% | -3.15% | +20.50% | +615.75% | 16.1B | |
| +0.46% | -3.05% | +31.49% | +135.18% | 12.48B | |
| Average | -0.65% | +5.22% | +53.83% | +202.84% | 26.83B | |
| Weighted average by Cap. | -0.27% | +4.01% | +51.08% | +165.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 169M 196M 25M 21.67M 20.31M 18.52M 34.85M 2.39B 35.41M 239M 93.38M 1.19B 93.86M 91.83M 3.98B | 159M 186M 23.65M 20.5M 19.21M 17.52M 32.96M 2.26B 33.49M 226M 88.32M 1.13B 88.78M 86.85M 3.77B |
| Net income | -391M -454M -57.9M -50.19M -47.05M -42.9M -80.72M -5.53B -82.01M -554M -216M -2.77B -217M -213M -9.23B | -276M -321M -40.91M -35.46M -33.25M -30.31M -57.04M -3.9B -57.95M -391M -153M -1.95B -154M -150M -6.52B |
| Net Debt | -807M -939M -120M -104M -97.2M -88.63M -167M -11.42B -169M -1.14B -447M -5.72B -449M -439M -19.07B | -545M -634M -80.82M -70.06M -65.67M -59.88M -113M -7.71B -114M -773M -302M -3.86B -303M -297M -12.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | HK$31.06 | -1.15% | 205,200 |
| 26-08-13 | HK$31.42 | +3.36% | 1,436,367 |
| 26-08-12 | HK$30.40 | -0.78% | 1,394,132 |
| 26-08-11 | HK$30.64 | -3.83% | 1,673,792 |
| 26-08-10 | HK$31.86 | +6.56% | 1,944,117 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2595 Stock
Select your edition
All financial news and data tailored to specific country editions
